Senior insider sale
Chief Scientific Officer at CARTESIAN THERAPEUTICS, INC. — senior position signals high conviction
$192.6K
26.93K shares
What this filing means
JEWELL CHRISTOPHER M plans to sell 26.93K shares of CARTESIAN THERAPEUTICS, INC. valued at approximately $192.6K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 11/19/2025ACC: 0001950047-25-009107
Officer· Chief Scientific Officer
Since Nov 2023
26.93K
Shares to sell
$192.6K
Approx. market value
26.93K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months3
Previously Exercised Options
Services Rendered
1/10/2025
9KRestricted stock vesting under a registered plan
Services Rendered
1/2/2025
3.94KPreviously Exercised Options
Services Rendered
11/15/2024
14KTotal acquired26.93K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
1/10/2025 | Previously Exercised Options Services Rendered | 9K | — |
1/2/2025 | Restricted stock vesting under a registered plan Services Rendered | 3.94K | — |
11/15/2024 | Previously Exercised Options Services Rendered | 14K | — |
| Total | 26.93K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
26.93K
Market value
$192.6K
11/19/2025
Total
Units
26.93K
Value
$192.6K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
11/19/2025 | 26.93K | $192.6K | NASDAQ | Planned |
| Total | 26.93K | $192.6K | ||